Fig. 3: Individual pure-tone audiograms (treated ear) of all patients that completed 12 weeks follow-up (N = 42). | Nature Communications

Fig. 3: Individual pure-tone audiograms (treated ear) of all patients that completed 12 weeks follow-up (N = 42).

From: A phase I/IIa safety and efficacy trial of intratympanic gamma-secretase inhibitor as a regenerative drug treatment for sensorineural hearing loss

Fig. 3

Presented timepoints are baseline (black circle), 6 (blue cross) and 12 (red triangles) weeks. Frequencies not shown indicate that thresholds are beyond the maximum output of the audiometer. Pure-tone thresholds are displayed in decibel hearing level (dB HL), frequency in kilohertz (kHz). Source data are provided as “supplementary data 4”.

Back to article page